• Tue news: Where do Harris and Trump stand on health policy? Medtronic renal denervation coverage. Canada less likely to have drug shortages? Wall Street wants CVS execution plan. Nektar manufacturing facility sale. See more on our front page

Anything new with Ophthalmology











Has anyone heard any news on Inspire? Will there managers be kept? Do us Merck reps have first dibs on any open territories?

This sale is fraught with problems. I would have loved to been a fly onthe wall when the Merck higherups were negotiating this dog of a sale..$430+ million for WHAT? Shareholder lawsuit and patent challenge on Azasite. Dont think Mother Merck thought this one through. There will be no open territories..Inspire Reps will have a retention bonus, so in their right mind would walk away from that kind of money!